SINGAPORE (Oct 27): OCBC is keeping its “hold” recommendation for Raffles Medical Group with a target price of $4.59.

In 3Q15, Raffles Medical’s revenue rose 7.4% to $101.5 million from a year ago, meeting 24.3% of OCBC’s full-year forecast.

Revenue from Hospital Services and Healthcare Services divisions had increased by 11.7% and 3.5% respectively, supported by volume growth of local patients.

To continue reading,

Sign in to access this Premium article.

Subscription entitlements:

Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)

Related Stories

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook